
Loading, please wait...

Loading, please wait...

Recent advancements in surgical technology allow for more precise and less invasive medical procedures. Specifically, single-port robotic adrenalectomy is gaining significant popularity among urologists and endocrine surgeons globally. A nationwide Korean study recently examined 303 patients to evaluate the safety of this single-port approach compared to traditional multi-port robotic surgery. Consequently, the researchers utilized propensity score matching to ensure an accurate comparison of perioperative outcomes. Furthermore, the analysis focused on tumor characteristics and laterality to maintain high statistical integrity.
The clinical data revealed that both robotic modalities are equally safe for patients. Specifically, intraoperative and postoperative complication rates showed no significant difference between the single-port and multi-port groups. Additionally, the average hospital stay remained consistent at approximately 4.3 days for both surgical types. Therefore, the single-port method does not compromise patient safety or clinical efficacy. However, the study noted that complication risks depend more on the specific tumor type, such as pheochromocytoma, rather than the choice of robotic platform. Consequently, single-port robotic adrenalectomy offers a viable alternative for surgeons aiming to minimize incision sites without increasing risk.
While the single-port system is newer, its application in partial adrenalectomy and retroperitoneal approaches is expanding. Specifically, the data suggests that tumor size does not necessarily limit the use of the single-port modality. Furthermore, experienced surgical teams can achieve excellent results even with complex tumor characteristics. Consequently, clinicians should consider patient-specific factors when choosing between robotic platforms. Therefore, this study confirms that both single-port and multi-port robotic adrenalectomies are safe and effective options for modern surgical care.
The primary benefits include improved cosmetic outcomes through a single incision and potentially reduced incision-related morbidity while maintaining similar surgical safety to traditional multi-port systems.
While both are safe, research indicates no significant difference in complications even when tumor sizes are stratified at 4 cm. Consequently, both techniques are effective for standard adrenal masses.
No, recent nationwide data shows that intraoperative and postoperative complication rates are not significantly different between single-port and multi-port robotic adrenalectomies.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Chung JW et al. Surgical Efficacy of Robotic Adrenalectomy: Korean Nationwide Comparative Data Analysis Focusing on Robotic Modality, Surgical Approach, and Tumor Characteristics. J Laparoendosc Adv Surg Tech A. 2026 Apr 19. doi: 10.1177/10926429251411372. PMID: 42001277.
Aliyev S et al. Single-Port Robotic-Assisted Adrenalectomy: Feasibility, Safety, and Cost-Effectiveness. Journal of Laparoendoscopic & Advanced Surgical Techniques. 2025.
Estevez A et al. Advancing Minimally Invasive Adrenalectomy: Is There a Benefit of the Robotic-Assisted Single Port Approach? NEAUA. 2024.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A Korean nationwide study finds that single-port robotic adrenalectomy is as safe as multi-port RA, offering comparable complication rates and hospital stay...
4 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today